| Literature DB >> 25404359 |
Thouraya Ben Safta1, Linda Ziani1, Loetitia Favre1, Lucille Lamendour1, Gwendoline Gros1, Fathia Mami-Chouaib1, Denis Martinvalet2, Salem Chouaib1, Jerome Thiery3.
Abstract
Granzyme B (GzmB) plays a major role in CTLs and NK cell-mediated elimination of virus-infected cells and tumors. Human GzmB preferentially induces target cell apoptosis by cleaving the proapoptotic Bcl-2 family member Bid, which, together with Bax, induces mitochondrial outer membrane permeabilization. We previously showed that GzmB also induces a rapid accumulation of the tumor-suppressor protein p53 within target cells, which seems to be involved in GzmB-induced apoptosis. In this article, we show that GzmB-activated p53 accumulates on target cell mitochondria and interacts with Bcl-2. This interaction prevents Bcl-2 inhibitory effect on both Bax and GzmB-truncated Bid, and promotes GzmB-induced mitochondrial outer membrane permeabilization. Consequently, blocking p53-Bcl-2 interaction decreases GzmB-induced Bax activation, cytochrome c release from mitochondria, and subsequent effector caspases activation leading to a decreased sensitivity of target cells to both GzmB and CTL/NK-mediated cell death. Together, our results define p53 as a new important player in the GzmB apoptotic signaling pathway and in CTL/NK-induced apoptosis.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25404359 DOI: 10.4049/jimmunol.1401978
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422